This activity is supported by an educational grant from Celgene and Merrimack Pharmaceuticals, Inc.

What Advanced Practitioners Need to Know About the Diagnosis and Treatment of Patients With Pancreatic Cancer

Joseph M. Herman, MD
University of Texas MD Anderson Cancer Center

Amy Hacker-Prietz, PA-C
Johns Hopkins University

Pancreatic cancer is known to carry a poor prognosis. Only 15%–20% of patients present with potentially resectable disease, and therefore accurate diagnosis and staging is essential. It is also important that providers are aware of emerging data and guidelines regarding second- and third-line treatment options. This educational activity will provide the advanced practitioner with important information regarding risk assessment, diagnostic workup, treatment considerations (including surgery, radiation, and chemotherapy), and supportive care.


Download Podcast

   To claim credit for podcast click here

Download Transcript


Download Slides


Download Slides & Transcripts

   To claim credit for the slides & transcript click here

These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here